Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,800 INR | +1.86% | +2.05% | +10.83% |
Sales 2024 | 34.84B 417M | Sales 2025 * | 40.51B 485M | Capitalization | 279B 3.35B |
---|---|---|---|---|---|
Net income 2024 | 5.53B 66.2M | Net income 2025 * | 7.03B 84.2M | EV / Sales 2024 | 7.35 x |
Net Debt 2024 * | 1.32B 15.79M | Net cash position 2025 * | 5.26B 62.97M | EV / Sales 2025 * | 6.77 x |
P/E ratio 2024 |
47.3
x | P/E ratio 2025 * |
39.8
x | Employees | 5,095 |
Yield 2024 * |
0.62% | Yield 2025 * |
0.83% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +1.86% | ||
1 week | +2.05% | ||
Current month | +2.05% | ||
1 month | +1.99% | ||
3 months | +13.36% | ||
6 months | +23.76% | ||
Current year | +10.83% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-10-04 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-30 | |
Akshay Tanna
BRD | Director/Board Member | 40 | Nov. 06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 21-02-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.30% | - | |
0.00% | 114 M€ | +4.36% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1,800 | +1.86% | 2,958 |
24-06-06 | 1,767 | -0.69% | 2,874 |
24-06-05 | 1,780 | +2.14% | 4,884 |
24-06-04 | 1,742 | -2.07% | 6,323 |
24-06-03 | 1,779 | +0.85% | 3,945 |
Delayed Quote Bombay S.E., June 07, 2024 at 06:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.83% | 3.35B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- JBCHEPHARM Stock